Cargando…
An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes
Smoking cigarettes is a major risk factor in the development and progression of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD). Modified risk tobacco products (MRTPs) are being developed to reduce smoking-related health risks. The goal of this study was to investigate...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725610/ https://www.ncbi.nlm.nih.gov/pubmed/26609137 http://dx.doi.org/10.1093/toxsci/kfv243 |
_version_ | 1782411653550178304 |
---|---|
author | Phillips, Blaine Veljkovic, Emilija Boué, Stéphanie Schlage, Walter K. Vuillaume, Gregory Martin, Florian Titz, Bjoern Leroy, Patrice Buettner, Ansgar Elamin, Ashraf Oviedo, Alberto Cabanski, Maciej De León, Héctor Guedj, Emmanuel Schneider, Thomas Talikka, Marja Ivanov, Nikolai V. Vanscheeuwijck, Patrick Peitsch, Manuel C. Hoeng, Julia |
author_facet | Phillips, Blaine Veljkovic, Emilija Boué, Stéphanie Schlage, Walter K. Vuillaume, Gregory Martin, Florian Titz, Bjoern Leroy, Patrice Buettner, Ansgar Elamin, Ashraf Oviedo, Alberto Cabanski, Maciej De León, Héctor Guedj, Emmanuel Schneider, Thomas Talikka, Marja Ivanov, Nikolai V. Vanscheeuwijck, Patrick Peitsch, Manuel C. Hoeng, Julia |
author_sort | Phillips, Blaine |
collection | PubMed |
description | Smoking cigarettes is a major risk factor in the development and progression of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD). Modified risk tobacco products (MRTPs) are being developed to reduce smoking-related health risks. The goal of this study was to investigate hallmarks of COPD and CVD over an 8-month period in apolipoprotein E-deficient mice exposed to conventional cigarette smoke (CS) or to the aerosol of a candidate MRTP, tobacco heating system (THS) 2.2. In addition to chronic exposure, cessation or switching to THS2.2 after 2 months of CS exposure was assessed. Engaging a systems toxicology approach, exposure effects were investigated using physiology and histology combined with transcriptomics, lipidomics, and proteomics. CS induced nasal epithelial hyperplasia and metaplasia, lung inflammation, and emphysematous changes (impaired pulmonary function and alveolar damage). Atherogenic effects of CS exposure included altered lipid profiles and aortic plaque formation. Exposure to THS2.2 aerosol (nicotine concentration matched to CS, 29.9 mg/m(3)) neither induced lung inflammation or emphysema nor did it consistently change the lipid profile or enhance the plaque area. Cessation or switching to THS2.2 reversed the inflammatory responses and halted progression of initial emphysematous changes and the aortic plaque area. Biological processes, including senescence, inflammation, and proliferation, were significantly impacted by CS but not by THS2.2 aerosol. Both, cessation and switching to THS2.2 reduced these perturbations to almost sham exposure levels. In conclusion, in this mouse model cessation or switching to THS2.2 retarded the progression of CS-induced atherosclerotic and emphysematous changes, while THS2.2 aerosol alone had minimal adverse effects. |
format | Online Article Text |
id | pubmed-4725610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-47256102016-01-26 An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes Phillips, Blaine Veljkovic, Emilija Boué, Stéphanie Schlage, Walter K. Vuillaume, Gregory Martin, Florian Titz, Bjoern Leroy, Patrice Buettner, Ansgar Elamin, Ashraf Oviedo, Alberto Cabanski, Maciej De León, Héctor Guedj, Emmanuel Schneider, Thomas Talikka, Marja Ivanov, Nikolai V. Vanscheeuwijck, Patrick Peitsch, Manuel C. Hoeng, Julia Toxicol Sci Evaluation of Cardiovascular and Respiratory Toxicity of Non-Burn Tobacco Smoking cigarettes is a major risk factor in the development and progression of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD). Modified risk tobacco products (MRTPs) are being developed to reduce smoking-related health risks. The goal of this study was to investigate hallmarks of COPD and CVD over an 8-month period in apolipoprotein E-deficient mice exposed to conventional cigarette smoke (CS) or to the aerosol of a candidate MRTP, tobacco heating system (THS) 2.2. In addition to chronic exposure, cessation or switching to THS2.2 after 2 months of CS exposure was assessed. Engaging a systems toxicology approach, exposure effects were investigated using physiology and histology combined with transcriptomics, lipidomics, and proteomics. CS induced nasal epithelial hyperplasia and metaplasia, lung inflammation, and emphysematous changes (impaired pulmonary function and alveolar damage). Atherogenic effects of CS exposure included altered lipid profiles and aortic plaque formation. Exposure to THS2.2 aerosol (nicotine concentration matched to CS, 29.9 mg/m(3)) neither induced lung inflammation or emphysema nor did it consistently change the lipid profile or enhance the plaque area. Cessation or switching to THS2.2 reversed the inflammatory responses and halted progression of initial emphysematous changes and the aortic plaque area. Biological processes, including senescence, inflammation, and proliferation, were significantly impacted by CS but not by THS2.2 aerosol. Both, cessation and switching to THS2.2 reduced these perturbations to almost sham exposure levels. In conclusion, in this mouse model cessation or switching to THS2.2 retarded the progression of CS-induced atherosclerotic and emphysematous changes, while THS2.2 aerosol alone had minimal adverse effects. Oxford University Press 2016-02 2015-11-25 /pmc/articles/PMC4725610/ /pubmed/26609137 http://dx.doi.org/10.1093/toxsci/kfv243 Text en © The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Evaluation of Cardiovascular and Respiratory Toxicity of Non-Burn Tobacco Phillips, Blaine Veljkovic, Emilija Boué, Stéphanie Schlage, Walter K. Vuillaume, Gregory Martin, Florian Titz, Bjoern Leroy, Patrice Buettner, Ansgar Elamin, Ashraf Oviedo, Alberto Cabanski, Maciej De León, Héctor Guedj, Emmanuel Schneider, Thomas Talikka, Marja Ivanov, Nikolai V. Vanscheeuwijck, Patrick Peitsch, Manuel C. Hoeng, Julia An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes |
title | An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes |
title_full | An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes |
title_fullStr | An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes |
title_full_unstemmed | An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes |
title_short | An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes |
title_sort | 8-month systems toxicology inhalation/cessation study in apoe(−/−) mice to investigate cardiovascular and respiratory exposure effects of a candidate modified risk tobacco product, ths 2.2, compared with conventional cigarettes |
topic | Evaluation of Cardiovascular and Respiratory Toxicity of Non-Burn Tobacco |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725610/ https://www.ncbi.nlm.nih.gov/pubmed/26609137 http://dx.doi.org/10.1093/toxsci/kfv243 |
work_keys_str_mv | AT phillipsblaine an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT veljkovicemilija an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT bouestephanie an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT schlagewalterk an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT vuillaumegregory an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT martinflorian an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT titzbjoern an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT leroypatrice an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT buettneransgar an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT elaminashraf an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT oviedoalberto an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT cabanskimaciej an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT deleonhector an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT guedjemmanuel an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT schneiderthomas an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT talikkamarja an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT ivanovnikolaiv an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT vanscheeuwijckpatrick an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT peitschmanuelc an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT hoengjulia an8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT phillipsblaine 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT veljkovicemilija 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT bouestephanie 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT schlagewalterk 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT vuillaumegregory 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT martinflorian 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT titzbjoern 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT leroypatrice 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT buettneransgar 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT elaminashraf 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT oviedoalberto 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT cabanskimaciej 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT deleonhector 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT guedjemmanuel 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT schneiderthomas 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT talikkamarja 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT ivanovnikolaiv 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT vanscheeuwijckpatrick 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT peitschmanuelc 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes AT hoengjulia 8monthsystemstoxicologyinhalationcessationstudyinapoemicetoinvestigatecardiovascularandrespiratoryexposureeffectsofacandidatemodifiedrisktobaccoproductths22comparedwithconventionalcigarettes |